---
kind: "unit"
title: "9"
title_heading: "Animals and Animal Products"
key: "chI/subchE/part113"
level: "part"
label: "Part 113"
heading: "Standard Requirements"
release: "ecfr-current"
date: "2026-08-27"
url: "https://uscodex.org/cfr/9/chI-subchE-part113"
sections_count: 125
---

# Part 113 — Standard Requirements

Title 9 C.F.R. — Animals and Animal Products › Chapter I — Animal and Plant Health Inspection Service, Department of Agriculture › Subchapter E — Viruses, Serums, Toxins, and Analogous Products; Organisms and Vectors

## Sections

- [§113.1. Compliance.](/cfr/9/113.1.md)
- [§113.2. Testing aids.](/cfr/9/113.2.md)
- [§113.3. Sampling of biological products.](/cfr/9/113.3.md)
- [§113.4. Exemptions to tests.](/cfr/9/113.4.md)
- [§113.5. General testing.](/cfr/9/113.5.md)
- [§113.6. Animal and Plant Health Inspection Service testing.](/cfr/9/113.6.md)
- [§113.7. Multiple fractions.](/cfr/9/113.7.md)
- [§113.8. In vitro tests for serial release.](/cfr/9/113.8.md)
- [§113.9. New potency test.](/cfr/9/113.9.md)
- [§113.10. Testing of bulk material for export or for further manufacture.](/cfr/9/113.10.md)
- [§113.25. Culture media for detection of bacteria and fungi.](/cfr/9/113.25.md)
- [§113.26. Detection of viable bacteria and fungi except in live vaccine.](/cfr/9/113.26.md)
- [§113.27. Detection of extraneous viable bacteria and fungi in live vaccines.](/cfr/9/113.27.md)
- [§113.28. Detection of mycoplasma contamination.](/cfr/9/113.28.md)
- [§113.29. Determination of moisture content in desiccated biological products.](/cfr/9/113.29.md)
- [§113.30. Detection of Salmonella contamination.](/cfr/9/113.30.md)
- [§113.31. Detection of avian lymphoid leukosis.](/cfr/9/113.31.md)
- [§113.32. Detection of Brucella contamination.](/cfr/9/113.32.md)
- [§113.33. Mouse safety tests.](/cfr/9/113.33.md)
- [§113.34. Detection of hemagglutinating viruses.](/cfr/9/113.34.md)
- [§113.35. Detection of viricidal activity.](/cfr/9/113.35.md)
- [§113.36. Detection of pathogens by the chicken inoculation test.](/cfr/9/113.36.md)
- [§113.37. Detection of pathogens by the chicken embryo inoculation test.](/cfr/9/113.37.md)
- [§113.38. Guinea pig safety test.](/cfr/9/113.38.md)
- [§113.39. Cat safety tests.](/cfr/9/113.39.md)
- [§113.40. Dog safety tests.](/cfr/9/113.40.md)
- [§113.41. Calf safety test.](/cfr/9/113.41.md)
- [§113.42. Detection of lymphocytic choriomeningitis contamination.](/cfr/9/113.42.md)
- [§113.43. Detection of chlamydial agents.](/cfr/9/113.43.md)
- [§113.44. Swine safety test.](/cfr/9/113.44.md)
- [§113.45. Sheep safety test.](/cfr/9/113.45.md)
- [§113.46. Detection of cytopathogenic and/or hemadsorbing agents.](/cfr/9/113.46.md)
- [§113.47. Detection of extraneous viruses by the fluorescent antibody technique.](/cfr/9/113.47.md)
- [§113.50. Ingredients of biological products.](/cfr/9/113.50.md)
- [§113.51. Requirements for primary cells used for production of biologics.](/cfr/9/113.51.md)
- [§113.52. Requirements for cell lines used for production of biologics.](/cfr/9/113.52.md)
- [§113.53. Requirements for ingredients of animal origin used for production of biologics.](/cfr/9/113.53.md)
- [§113.54. Sterile diluent.](/cfr/9/113.54.md)
- [§113.55. Detection of extraneous agents in Master Seed Virus.](/cfr/9/113.55.md)
- [§113.64. General requirements for live bacterial vaccines.](/cfr/9/113.64.md)
- [§113.65. Brucella Abortus Vaccine.](/cfr/9/113.65.md)
- [§113.66. Anthrax Spore Vaccine—Nonencapsulated.](/cfr/9/113.66.md)
- [§113.67. Erysipelothrix Rhusiopathiae Vaccine.](/cfr/9/113.67.md)
- [§113.68. Pasteurella Haemolytica Vaccine, Bovine.](/cfr/9/113.68.md)
- [§113.69. Pasteurella Multocida Vaccine, Bovine.](/cfr/9/113.69.md)
- [§113.70. Pasteurella Multocida Vaccine, Avian Isolate.](/cfr/9/113.70.md)
- [§113.71. Chlamydia Psittaci Vaccine (Feline Pneumonitis), Live Chlamydia.](/cfr/9/113.71.md)
- [§113.100. General requirements for inactivated bacterial products.](/cfr/9/113.100.md)
- [§113.101. Leptospira Pomona Bacterin.](/cfr/9/113.101.md)
- [§113.102. Leptospira Icterohaemorrhagiae Bacterin.](/cfr/9/113.102.md)
- [§113.103. Leptospira Canicola Bacterin.](/cfr/9/113.103.md)
- [§113.104. Leptospira Grippotyphosa Bacterin.](/cfr/9/113.104.md)
- [§113.105. Leptospira Hardjo Bacterin.](/cfr/9/113.105.md)
- [§113.106. Clostridium Chauvoei Bacterin.](/cfr/9/113.106.md)
- [§113.107. Clostridium Haemolyticum Bacterin.](/cfr/9/113.107.md)
- [§113.108. Clostridium Novyi Bacterin-Toxoid.](/cfr/9/113.108.md)
- [§113.109. Clostridium Sordellii Bacterin-Toxoid.](/cfr/9/113.109.md)
- [§113.110. Clostridium Botulinum Type C Bacterin-Toxoid.](/cfr/9/113.110.md)
- [§113.111. Clostridium Perfringens Type C Toxoid and Bacterin-Toxoid.](/cfr/9/113.111.md)
- [§113.112. Clostridium Perfringens Type D Toxoid and Bacterin-Toxoid.](/cfr/9/113.112.md)
- [§113.113. Autogenous biologics.](/cfr/9/113.113.md)
- [§113.114. Tetanus Toxoid.](/cfr/9/113.114.md)
- [§113.115. Staphylococcus Aureus Bacterin-Toxoid.](/cfr/9/113.115.md)
- [§113.116. Pasteurella Multocida Bacterin, Avian Isolate, Type 4.](/cfr/9/113.116.md)
- [§113.117. Pasteurella Multocida Bacterin, Avian Isolate, Type 1.](/cfr/9/113.117.md)
- [§113.118. Pasteurella Multocida Bacterin, Avian Isolate, Type 3.](/cfr/9/113.118.md)
- [§113.119. Erysipelothrix Rhusiopathiae Bacterin.](/cfr/9/113.119.md)
- [§113.120. Salmonella Typhimurium Bacterin.](/cfr/9/113.120.md)
- [§113.121. Pasteurella Multocida Bacterin.](/cfr/9/113.121.md)
- [§113.122. Salmonella Choleraesuis Bacterin.](/cfr/9/113.122.md)
- [§113.123. Salmonella Dublin Bacterin.](/cfr/9/113.123.md)
- [§113.200. General requirements for killed virus vaccines.](/cfr/9/113.200.md)
- [§113.201-113.203. Reserved](/cfr/9/113.201-113.203.md)
- [§113.204. Mink Enteritis Vaccine, Killed Virus.](/cfr/9/113.204.md)
- [§113.205. Newcastle Disease Vaccine, Killed Virus.](/cfr/9/113.205.md)
- [§113.206. Wart Vaccine, Killed Virus.](/cfr/9/113.206.md)
- [§113.207. Encephalomyelitis Vaccine, Eastern, Western, and Venezuelan, Killed Virus.](/cfr/9/113.207.md)
- [§113.208. Avian Encephalomyelitis Vaccine, Killed Virus.](/cfr/9/113.208.md)
- [§113.209. Rabies Vaccine, Killed Virus.](/cfr/9/113.209.md)
- [§113.210. Feline Calicivirus Vaccine, Killed Virus.](/cfr/9/113.210.md)
- [§113.211. Reserved](/cfr/9/113.211.md)
- [§113.212. Bursal Disease Vaccine, Killed Virus.](/cfr/9/113.212.md)
- [§113.213-113.214. Reserved](/cfr/9/113.213-113.214.md)
- [§113.215. Bovine Virus Diarrhea Vaccine, Killed Virus.](/cfr/9/113.215.md)
- [§113.216. Bovine Rhinotracheitis Vaccine, Killed Virus.](/cfr/9/113.216.md)
- [§113.300. General requirements for live virus vaccines.](/cfr/9/113.300.md)
- [§113.301. Ovine Ecthyma Vaccine.](/cfr/9/113.301.md)
- [§113.302. Distemper Vaccine—Mink.](/cfr/9/113.302.md)
- [§113.303. Bluetongue Vaccine.](/cfr/9/113.303.md)
- [§113.304. Feline Panleukopenia Vaccine.](/cfr/9/113.304.md)
- [§113.305. Canine Hepatitis and Canine Adenovirus Type 2 Vaccine.](/cfr/9/113.305.md)
- [§113.306. Canine Distemper Vaccine.](/cfr/9/113.306.md)
- [§113.308. Encephalomyelitis Vaccine, Venezuelan.](/cfr/9/113.308.md)
- [§113.309. Bovine Parainfluenza 3 Vaccine.](/cfr/9/113.309.md)
- [§113.310. Bovine Rhinotracheitis Vaccine.](/cfr/9/113.310.md)
- [§113.311. Bovine Virus Diarrhea Vaccine.](/cfr/9/113.311.md)
- [§113.312. Rabies Vaccine, Live Virus.](/cfr/9/113.312.md)
- [§113.313. Measles Vaccine.](/cfr/9/113.313.md)
- [§113.314. Feline Calicivirus Vaccine.](/cfr/9/113.314.md)
- [§113.315. Feline Rhinotracheitis Vaccine.](/cfr/9/113.315.md)
- [§113.316. Canine Parainfluenza Vaccine.](/cfr/9/113.316.md)
- [§113.317. Parvovirus Vaccine (Canine).](/cfr/9/113.317.md)
- [§113.318. Pseudorabies Vaccine.](/cfr/9/113.318.md)
- [§113.319-113.324. Reserved](/cfr/9/113.319-113.324.md)
- [§113.325. Avian Encephalomyelitis Vaccine.](/cfr/9/113.325.md)
- [§113.326. Avian Pox Vaccine.](/cfr/9/113.326.md)
- [§113.327. Bronchitis Vaccine.](/cfr/9/113.327.md)
- [§113.328. Fowl Laryngotracheitis Vaccine.](/cfr/9/113.328.md)
- [§113.329. Newcastle Disease Vaccine.](/cfr/9/113.329.md)
- [§113.330. Marek's Disease Vaccines.](/cfr/9/113.330.md)
- [§113.331. Bursal Disease Vaccine.](/cfr/9/113.331.md)
- [§113.332. Tenosynovitis Vaccine.](/cfr/9/113.332.md)
- [§113.400-113.405. Reserved](/cfr/9/113.400-113.405.md)
- [§113.406. Tuberculin, Intradermic.](/cfr/9/113.406.md)
- [§113.407. Pullorum antigen.](/cfr/9/113.407.md)
- [§113.408. Avian mycoplasma antigen.](/cfr/9/113.408.md)
- [§113.409. Tuberculin—PPD Bovis, Intradermic.](/cfr/9/113.409.md)
- [§113.450. General requirements for antibody products.](/cfr/9/113.450.md)
- [§113.451. Tetanus Antitoxin.](/cfr/9/113.451.md)
- [§113.452. Erysipelothrix Rhusiopathiae Antibody.](/cfr/9/113.452.md)
- [§113.453. Reserved](/cfr/9/113.453.md)
- [§113.454. Clostridium Perfringens Type C Antitoxin.](/cfr/9/113.454.md)
- [§113.455. Clostridium Perfringens Type D Antitoxin.](/cfr/9/113.455.md)
- [§113.456-113.498. Reserved](/cfr/9/113.456-113.498.md)
- [§113.499. Products for treatment of failure of passive transfer.](/cfr/9/113.499.md)